03.05.19
|
|
Bristol-Myers Squibb overweight
|
Barclays Capital
|
07.12.18
|
|
Bristol-Myers Squibb Outperform
|
BMO Capital Markets
|
27.04.18
|
|
Bristol-Myers Squibb Market Perform
|
BMO Capital Markets
|
15.02.18
|
|
Bristol-Myers Squibb overweight
|
Morgan Stanley
|
05.05.17
|
|
Bristol-Myers Squibb Underperform
|
BMO Capital Markets
|
28.10.16
|
|
Bristol-Myers Squibb Hold
|
Deutsche Bank AG
|
09.09.16
|
|
Bristol-Myers Squibb Equal weight
|
Barclays Capital
|
23.05.16
|
|
Bristol-Myers Squibb Neutral
|
J.J.B. Hilliard, W.L. Lyons, Inc.
|
|
29.04.16
|
|
Bristol-Myers Squibb Equal weight
|
Barclays Capital
|
29.04.16
|
|
Bristol-Myers Squibb Buy
|
UBS AG
|
01.12.15
|
|
Bristol-Myers Squibb Equal weight
|
Barclays Capital
|
27.02.15
|
|
Bristol-Myers Squibb Buy
|
Argus Research Company
|
12.01.15
|
|
Bristol-Myers Squibb Buy
|
Argus Research Company
|
27.10.14
|
|
Bristol-Myers Squibb Sell
|
MKM Partners
|
17.10.14
|
|
Bristol-Myers Squibb Outperform
|
BMO Capital Markets
|
02.07.14
|
|
Bristol-Myers Squibb Equal weight
|
Barclays Capital
|
12.07.13
|
|
Bristol-Myers Squibb halten
|
Jefferies & Company Inc.
|
10.12.12
|
|
Bristol-Myers Squibb neutral
|
UBS AG
|
03.12.12
|
|
Bristol-Myers Squibb neutral
|
Citigroup Corp.
|
12.09.12
|
|
Bristol-Myers Squibb buy
|
Goldman Sachs Group Inc.
|
02.08.12
|
|
Bristol-Myers Squibb neutral
|
UBS AG
|
26.07.12
|
|
Bristol-Myers Squibb neutral
|
UBS AG
|
20.07.12
|
|
Bristol-Myers Squibb neutral
|
UBS AG
|
22.06.12
|
|
Bristol-Myers Squibb neutral
|
Credit Suisse Group
|
30.04.12
|
|
Bristol-Myers Squibb overweight
|
Barclays Capital
|
30.01.12
|
|
Bristol-Myers Squibb overweight
|
Barclays Capital
|
10.01.12
|
|
Bristol-Myers Squibb overweight
|
Barclays Capital
|
08.11.11
|
|
Bristol-Myers Squibb buy
|
Citigroup Corp.
|
31.10.11
|
|
Bristol-Myers Squibb overweight
|
Barclays Capital
|
27.10.11
|
|
Bristol-Myers Squibb neutral
|
UBS AG
|
26.10.11
|
|
Bristol-Myers Squibb buy
|
Citigroup Corp.
|
06.10.11
|
|
Bristol-Myers Squibb buy
|
Banc of America Securities-Merrill Lynch
|
03.08.11
|
|
Bristol-Myers Squibb buy
|
Citigroup Corp.
|
01.08.11
|
|
Bristol-Myers Squibb buy
|
Citigroup Corp.
|
21.07.11
|
|
Bristol-Myers Squibb overweight
|
Barclays Capital
|
20.07.11
|
|
Bristol-Myers Squibb buy
|
Citigroup Corp.
|
12.07.11
|
|
Bristol-Myers Squibb buy
|
Citigroup Corp.
|
27.06.11
|
|
Bristol-Myers Squibb neutral
|
UBS AG
|
27.06.11
|
|
Bristol-Myers Squibb neutral
|
UBS AG
|
24.06.11
|
|
Bristol-Myers Squibb buy
|
Citigroup Corp.
|
24.06.11
|
|
Bristol-Myers Squibb buy
|
Citigroup Corp.
|
24.06.11
|
|
Bristol-Myers Squibb overweight
|
Barclays Capital
|
24.06.11
|
|
Bristol-Myers Squibb neutral
|
Credit Suisse Group
|
24.06.11
|
|
Bristol-Myers Squibb overweight
|
Morgan Stanley
|
23.06.11
|
|
Bristol-Myers Squibb neutral
|
UBS AG
|
15.06.11
|
|
Bristol-Myers Squibb neutral
|
UBS AG
|
01.06.11
|
|
Bristol-Myers Squibb buy
|
Citigroup Corp.
|
12.05.11
|
|
Bristol-Myers Squibb neutral
|
Goldman Sachs Group Inc.
|
02.05.11
|
|
Bristol-Myers Squibb overweight
|
Barclays Capital
|
19.04.11
|
|
Bristol-Myers Squibb overweight
|
Barclays Capital
|